Abstract:Cell Competition is a process by which neighboring cells compare their fitness. As a result, viable but suboptimal cells are selectively eliminated in the presence of fitter cells. In the early mammalian embryo, epiblast pluripotent cells undergo extensive Cell Competition, which prevents suboptimal cells from contributing to the newly forming organism. While competitive ability is regulated by MYC in the epiblast, the mechanisms that contribute to competitive fitness in this context are largely unknown. Here, we report that P53 and its pro-apoptotic targets PUMA and NOXA regulate apoptosis susceptibility and competitive fitness in pluripotent cells. PUMA is widely expressed specifically in pluripotent cells in vitro and in vivo . We found that P53 regulates MYC levels in pluripotent cells, which connects these two Cell competition pathways, however, MYC and PUMA/NOXA levels are independently regulated by P53. We propose a model that integrates a bifurcated P53 pathway regulating both MYC and PUMA/NOXA levels and determines competitive fitness. Cells compete with neighbors for survival in several situations in vitro and in vivo . In mammalian embryos, this phenomenon takes place among pluripotent cells, which are those able to form all the tissues of a new organism. Cell Competition in this context is thought to function as a quality check for the elimination of potentially damaged or dangerous cells (losers) whenever "fitter" cells (winners) are present. Here, we explored the molecular features of winner and loser pluripotent cells and uncovered a pathway that drives the ability of cells to compete. This pathway is governed by p53, a known factor that responds to stress and modulates cell death in several contexts, including cancer. Downstream this pathway, we found that p53 controls Cell Competition by regulating two independent branches; one involving the regulation of MYC, an oncogene previously known to regulate Competition in pluripotent cells, and a second one involving two mitochondrial factors known to regulate cell death and metabolism. Our work uncovers new mechanisms of pluripotent cell competition and show that the p53 cellular stress response pathway is involved in this developmental process.

Cell competition constitutes a barrier for interspecies chimerism

Ephrin Forward Signaling Controls Interspecies Cell Competition in Pluripotent Stem Cells

RNA Sensing and Innate Immunity Constitutes a Barrier for Interspecies Chimerism

Incompatibility in cell adhesion constitutes a barrier to interspecies chimerism

Growth Competition in Interspecies Chimeras: A New Paradigm for Blastocyst Complementation

Fitness selection in human pluripotent stem cells and interspecies chimeras: Implications for human development and regenerative medicine

P53 and BCL-2 family proteins PUMA and NOXA define competitive fitness in pluripotent cell competition

An Alternative Pluripotent State Confers Interspecies Chimaeric Competency.

Interspecies Chimerism with Mammalian Pluripotent Stem Cells.

Interspecies chimeras for human stem cell research

Cell Competition Eliminates Aneuploid Human Pluripotent Stem Cells

Interspecific in vitro assay for the chimera-forming ability of human pluripotent stem cells

Generating Functional Cells Through Enhanced Interspecies Chimerism with Human Pluripotent Stem Cells

Cross-species single-cell transcriptomic analysis reveals pre-gastrulation developmental differences among pigs, monkeys, and humans

Chimerism as the basis for organ repair

Mechanisms of Germline Stem Cell Competition across Species

Contributions of Mammalian Chimeras to Pluripotent Stem Cell Research

Derivation of Intermediate Pluripotent Stem Cells Amenable to Primordial Germ Cell Specification

To not love thy neighbor: mechanisms of cell competition in stem cells and beyond

Improving Cell Survival in Injected Embryos Allows Primed Pluripotent Stem Cells to Generate Chimeric Cynomolgus Monkeys.

Mammalian Cell Competitions, Cell-in-Cell Phenomena and Their Biomedical Implications.